This activity already occurred and is no longer available.
Clinical Trials Network Mid-Winter Meeting Workshop 2011 - Clinical Trials Regulations and Implementation - Part II
Clinical Trials Network Mid-Winter Meeting Workshop 2011 - Clinical Trials Regulations and Implementation - Part II
Clinical Trials Network Mid-Winter Meeting Workshop 2011 - Clinical Trials Regulations and Implementation - Part II

Release date: 10-12-12
Expiration date: 10-12-15

Authors


LisaAnn Trembath, CNMT, MSM, CCRA, NCT, FS, has nothing to disclose.

Gustav K. von Schulthess, MD, PhD, MD hon, is a consultant, investigator, and lecturer for Bayer-Schering Pharmaceuticals, a consultant for EHL Luxembourg govt., a consultant and researcher for GE Healthcare, and a consultant for ICON Medical.

Sally W. Schwarz, MS, RPh, BCNP, is a consultant for Avid Radiopharmaceutical.

Paul E. Christian, CNMT, BS, PET, has nothing to disclose.

Alexander Yordanov, PhD, is employed by Bioscan, Inc.

Peter S. Conti, MD, PhD, has nothing to disclose.

Target Audience
Physicians, pharmacists, and technologists

Objectives
At the completion of this activity, the participant will be able to:

 

1. Discuss the essential regulations that govern performing clinical research on humans.
2. Describe the role of imaging personnel in regards to source documentation and reporting adverse events.
3. Discuss the key elements for achieving standardization in imaging trials and its impact on drug development.


Continuing Education Credit Information

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

SNMMI designates this enduring material for a maximum of 4.0 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation. Release date: 10-12-12 Expiration date: 10-12-15



   

ACPE (Pharmacists)
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been designated as knowledge-based CPE. The universal program number for this enduring material is 0210-0000-12-389-H04-P. Total available credit for pharmacists is 3.75 hours or 0.0375 CEUs. Release Date: 10-12-12 Expiration Date: 10-12-15 To receive CE credit, learners must achieve a score of 80% on the post-course assessment and complete the evaluation.


VOICE (Technologists)

The SNMMI, through its Verification of Involvement in Continuing Education (VOICE) program, has approved this journal article for a maximum of 4 continuing education hours (CEHs). VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A credit. In order to receive CE credit, you must first complete the activity content. When completed, take the post-test assessment. You must obtain a score of 80% to receive the CE credit. You will have no more than 3 attempts to successfully complete the post-test. Release Date: 10-12-12 Expiration Date: 10-12-15 California Scope: 4.0 Imaging(I)/Non-Imaging(NI) / Radiopharmacy(R) / Therapy(T).

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (
http://get.adobe.com/reader/)

For questions please contact the
Education Department.
©2014 SNMMI. All rights reserved.

For more information on our privacy policy, please click the link below.


Type:     Internet Activity (Enduring Material)
24 Registered Users